Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthi Petrou

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Molecules (Basel, Switzerland)|April 13, 2023
Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro StudyDuangjai Todsaporn, Alexander Zubenko, Victor Kartsev, et al.
Molecules (Basel, Switzerland)|January 30, 2021
New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5<i>H</i>)ones as Possible Anti-Inflammatory AgentsChristophe Tratrat, Michelyne Haroun, Aliki Paparisva, et al.
International Journal of Molecular Sciences|October 29, 2025
Investigating Amphoteric 3,4'-Biscoumarin-Based <i>ortho</i>-[(Dialkylamino)methyl]phenols as Dual MAO and ChE InhibitorsAnthi Petrou, Caterina Deruvo, Rosa Purgatorio, et al.
Molecules (Basel, Switzerland)|September 13, 2025
Design, Synthesis, and In Vitro and In Silico Study of New Hybrid 1-(2-(4-Arylthiazol-2-yl)hydrazineylidene)-5,6-dihydro-4<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-2-ones as Factor Xa and Factor XIa InhibitorsAnna A Skoptsova, Athina Geronikaki, Anthi Petrou, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase InhibitorsAndrea Angeli, Victor Kartsev, Anthi Petrou, et al.
Steroids|February 19, 2019
Novel antimicrobial agents' discovery among the steroid derivativesNanuli Sh Nadaraia, Lela Sh Amiranashvili, Maia Merlani, et al.
Chemmedchem|May 7, 2024
Phthalazine Sulfonamide Derivatives as Carbonic Anhydrase Inhibitors. Synthesis, Biological and in silico EvaluationAndrea Angeli, Anthi Petrou, Viktor G Kartsev, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine DerivativesVolodymyr Horishny, Athina Geronikaki, Victor Kartsev, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Synthesis and Neurotropic Activity of New Heterocyclic Systems: Pyridofuro[3,2-<i>d</i>]pyrrolo[1,2-<i>a</i>]pyrimidines, Pyridofuro[3,2-<i>d</i>]pyrido[1,2-<i>a</i>]pyrimidines and Pyridofuro[3',2':4,5]pyrimido[1,2-<i>a</i>]azepinesSamvel N Sirakanyan, Domenico Spinelli, Athina Geronikaki, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico StudiesMichelyne Haroun, Anthi Petrou, Christophe Tratrat, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Molecules (Basel, Switzerland)|April 13, 2023
Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro StudyDuangjai Todsaporn, Alexander Zubenko, Victor Kartsev, et al.
Molecules (Basel, Switzerland)|January 30, 2021
New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5<i>H</i>)ones as Possible Anti-Inflammatory AgentsChristophe Tratrat, Michelyne Haroun, Aliki Paparisva, et al.
International Journal of Molecular Sciences|October 29, 2025
Investigating Amphoteric 3,4'-Biscoumarin-Based <i>ortho</i>-[(Dialkylamino)methyl]phenols as Dual MAO and ChE InhibitorsAnthi Petrou, Caterina Deruvo, Rosa Purgatorio, et al.
Molecules (Basel, Switzerland)|September 13, 2025
Design, Synthesis, and In Vitro and In Silico Study of New Hybrid 1-(2-(4-Arylthiazol-2-yl)hydrazineylidene)-5,6-dihydro-4<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-2-ones as Factor Xa and Factor XIa InhibitorsAnna A Skoptsova, Athina Geronikaki, Anthi Petrou, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase InhibitorsAndrea Angeli, Victor Kartsev, Anthi Petrou, et al.
Steroids|February 19, 2019
Novel antimicrobial agents' discovery among the steroid derivativesNanuli Sh Nadaraia, Lela Sh Amiranashvili, Maia Merlani, et al.
Chemmedchem|May 7, 2024
Phthalazine Sulfonamide Derivatives as Carbonic Anhydrase Inhibitors. Synthesis, Biological and in silico EvaluationAndrea Angeli, Anthi Petrou, Viktor G Kartsev, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine DerivativesVolodymyr Horishny, Athina Geronikaki, Victor Kartsev, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Synthesis and Neurotropic Activity of New Heterocyclic Systems: Pyridofuro[3,2-<i>d</i>]pyrrolo[1,2-<i>a</i>]pyrimidines, Pyridofuro[3,2-<i>d</i>]pyrido[1,2-<i>a</i>]pyrimidines and Pyridofuro[3',2':4,5]pyrimido[1,2-<i>a</i>]azepinesSamvel N Sirakanyan, Domenico Spinelli, Athina Geronikaki, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico StudiesMichelyne Haroun, Anthi Petrou, Christophe Tratrat, et al.
Pageof 8